Based on this article: https://doi.org/10.3389/fpubh.2018.00125 Was… Based on this article:https://doi.org/10.3389/fpubh.2018.00125 Was tr

Based on this article: https://doi.org/10.3389/fpubh.2018.00125 Was… Based on this article:https://doi.org/10.3389/fpubh.2018.00125 Was true randomisation used for assignment of participants to treatment groups?  Were treatment groups similar at baseline? Was allocation to treatment groups concealed? Were participants blind to treatment assignment? Were those delivering treatment blind to treatment assignment? Were outcome assessors blind to treatment assignment? Were treatment groups treated identically other than the intervention of interest?  Was follow up complete and if not, were differences between groups in terms of their follow up adequately described and analysed? Were participants analysed in the groups to which they were randomised? (Intention to treat analyses). Were outcomes measured in the same way for treatment groups? Were outcomes measured in a reliable way? Was appropriate statistical analysis used? Was the trial design appropriate, and any deviations from the standard RCT design accounted for in the conduct and analysis of the trial?  Science Health Science PUBLIC HEALTH 201,203 Share QuestionEmailCopy link